Relationship between SARS-CoV-2 infection and ICU-acquired candidemia in critically ill medical patients: a multicenter prospective cohort study.
COVID-19
Candidaemia
Healthcare associated infection
ICU
Journal
Critical care (London, England)
ISSN: 1466-609X
Titre abrégé: Crit Care
Pays: England
ID NLM: 9801902
Informations de publication
Date de publication:
27 Sep 2024
27 Sep 2024
Historique:
received:
19
08
2024
accepted:
17
09
2024
medline:
28
9
2024
pubmed:
28
9
2024
entrez:
28
9
2024
Statut:
epublish
Résumé
While SARS-CoV2 infection has been shown to be a significant risk-factor for several secondary bacterial, viral and Aspergillus infections, its impact on intensive care unit (ICU)-acquired candidemia (ICAC) remains poorly explored. Using the REA-REZO network (French surveillance network of ICU-acquired infections), we included all adult patients hospitalized for a medical reason of admission in participating ICUs for at least 48 h from January 2020 to January 2023. To account for confounders, a non-parsimonious propensity score matching was performed. Rates of ICAC according to SARS-CoV2 status were compared in matched patients. Factors associated with ICAC in COVID-19 patients were also assessed using a Fine-Gray model. A total of 55,268 patients hospitalized at least 48 h for a medical reason in 101 ICUs were included along the study period. Of those, 13,472 were tested positive for a SARS-CoV2 infection while 284 patients developed an ICAC. ICAC rate was higher in COVID-19 patients in both the overall population and the matched patients' cohort (0.8% (107/13,472) versus 0.4% (173/41,796); p < 0.001 and 0.8% (93/12,241) versus 0.5% (57/12,241); p = 0.004, respectively). ICAC incidence rate was also higher in those patients (incidence rate 0.51 per 1000 patients-days in COVID-19 patients versus 0.32 per 1000 patients-days; incidence rate ratio: 1.58 [95% CI:1.08-2.35]; p = 0.018). Finally, patients with ICAC had a higher ICU mortality rate (49.6% versus 20.2%; p < 0.001). In this large multicenter cohort of ICU patients, although remaining low, the rate of ICAC was higher among COVID-19 patients.
Sections du résumé
BACKGROUND
BACKGROUND
While SARS-CoV2 infection has been shown to be a significant risk-factor for several secondary bacterial, viral and Aspergillus infections, its impact on intensive care unit (ICU)-acquired candidemia (ICAC) remains poorly explored.
METHOD
METHODS
Using the REA-REZO network (French surveillance network of ICU-acquired infections), we included all adult patients hospitalized for a medical reason of admission in participating ICUs for at least 48 h from January 2020 to January 2023. To account for confounders, a non-parsimonious propensity score matching was performed. Rates of ICAC according to SARS-CoV2 status were compared in matched patients. Factors associated with ICAC in COVID-19 patients were also assessed using a Fine-Gray model.
RESULTS
RESULTS
A total of 55,268 patients hospitalized at least 48 h for a medical reason in 101 ICUs were included along the study period. Of those, 13,472 were tested positive for a SARS-CoV2 infection while 284 patients developed an ICAC. ICAC rate was higher in COVID-19 patients in both the overall population and the matched patients' cohort (0.8% (107/13,472) versus 0.4% (173/41,796); p < 0.001 and 0.8% (93/12,241) versus 0.5% (57/12,241); p = 0.004, respectively). ICAC incidence rate was also higher in those patients (incidence rate 0.51 per 1000 patients-days in COVID-19 patients versus 0.32 per 1000 patients-days; incidence rate ratio: 1.58 [95% CI:1.08-2.35]; p = 0.018). Finally, patients with ICAC had a higher ICU mortality rate (49.6% versus 20.2%; p < 0.001).
CONCLUSION
CONCLUSIONS
In this large multicenter cohort of ICU patients, although remaining low, the rate of ICAC was higher among COVID-19 patients.
Identifiants
pubmed: 39334254
doi: 10.1186/s13054-024-05104-w
pii: 10.1186/s13054-024-05104-w
doi:
Types de publication
Journal Article
Multicenter Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
320Investigateurs
Serge Alfandari
(S)
Alexandra Allaire
(A)
Antonio Alvarez
(A)
Ammenouche Nacim
(A)
Laurent Argaus
(L)
Gérard Audibert
(G)
Caroline Aurel
(C)
Odile Bajolet
(O)
Frédéric Barbut
(F)
Genevieve Barjon
(G)
Patricia Baune
(P)
Sébastien Beague
(S)
Bassam Beilouny
(B)
Nicolas Bele
(N)
Nicolas Belin
(N)
Cécile Bernerd
(C)
Yasmina Berrouane
(Y)
Aziz Berrouba
(A)
Julie Bertrand
(J)
Claire Bianchi
(C)
Sandrine Biangoma
(S)
Fabienne Birot Jaulin
(F)
Severine Bonjean
(S)
Stéphanie Bordes-Couecou
(S)
Abdenour Bouhara
(A)
Philippe Bouillard
(P)
Céline Bourigault
(C)
Sylvie Bourzeix
(S)
Sébastien Boutreux
(S)
Hanene Bouzidi
(H)
Julie Brochart
(J)
Stéphanie Bulyez
(S)
Marie Callanquin
(M)
Nathalie Canu
(N)
Matthieu Capron
(M)
Daniel Carbognani
(D)
Vincent Castelain
(V)
Vincent Catanese
(V)
Isabelle Cattaneo
(I)
Vanessa Chartier
(V)
Guillaume Chassaing
(G)
Robert Chausset
(R)
Mélanie Chauvet
(M)
Fabrice Chopin
(F)
Catherine Chubilleau
(C)
Céline Clayer
(C)
Agnès Cohen
(A)
Sylvie Comparot
(S)
Philippe Corne
(P)
Marie-Elisabeth Cornesse
(ME)
Gaelle Corno
(G)
Esther Cortes
(E)
Patricia Courouble
(P)
Christian Crombe
(C)
Véronique Curnier
(V)
Monzer Dabbachi
(M)
Cédric Dananché
(C)
Abla Daroukh
(A)
Damien Dassant
(D)
Martine Daumas
(M)
Aurélien Daurat
(A)
Dominique Deffarges
(D)
Fanny Delanghe
(F)
Olivier Delastre
(O)
Joel Delhomme
(J)
Jean Paul Délias
(JP)
Martine Delorme
(M)
Fabienne Derramond
(F)
Frédérique Diaw
(F)
Isabelle Dijols
(I)
Kamel Djedaini
(K)
Loic Dopeux
(L)
Sophie Duhoo
(S)
Thierry Dulac
(T)
Clarisse Dupin
(C)
Laurène Dupont
(L)
Michel Durand
(M)
Isabelle Durand Joly
(I)
Jean-Yves Dusseau
(JY)
Pierre Yves Egreteau
(PY)
Carole Eldin
(C)
Florence Espinasse
(F)
Eric Farfour
(E)
Abdelhamid Fatah
(A)
Yannick Fedun
(Y)
Luis Ferreira
(L)
Pierre Fillatre
(P)
Toufic Finge
(T)
Véronique Fleurial
(V)
Arnaud Florentin
(A)
Agnès Fribourg
(A)
Severine Gallais-Hoff
(S)
Claude Galland
(C)
Richard Galliot
(R)
Sylvain Garnier
(S)
Gaelle Gasan
(G)
Julien Gaubert-Duclos
(J)
Valérie Gauzere
(V)
Thomas Geffriaud
(T)
Isabelle Geneau
(I)
Hughes Georges
(H)
Solweig Gerbier Colomban
(S)
Christophe Giacardi
(C)
Sebastien Gibot
(S)
Audrey Glanard
(A)
Marion Gleize
(M)
Marieline Goret
(M)
Michele Gourgues
(M)
Delphine Grau
(D)
Béatrice Grisi
(B)
Clotilde Groleau
(C)
Liliane Grolier-Bois
(L)
Catherine Guignabert
(C)
Fethi Hadj-Slimane
(F)
Emmanuelle Hammad
(E)
Catherine Haond
(C)
Marie Hélène Hausermann
(MH)
Francoise Hayo
(F)
Christophe Henry
(C)
Alexandre Herbland
(A)
Julien Huntzinger
(J)
Hervé Hyvernat
(H)
Alexandre Jean
(A)
Boris Jolibois
(B)
Sylvie Joron
(S)
Gauthier Julien
(G)
Jean Kempf
(J)
Lyes Knani
(L)
Béatrice La Combe
(B)
Marie Labruyere
(M)
Sandrine Lacroix
(S)
Bruno Lafon
(B)
Katia Lamant
(K)
Peggy Larroudé
(P)
Anne Launoy
(A)
Bernadette Laurent
(B)
Thierry Lavigne
(T)
Christine Lawrence
(C)
Quoc Vien Le
(QV)
Muriel Le Coq
(M)
Anne-Sophie Le Floch
(AS)
Fanny Le Fall
(F)
Brigitte Le Tallec
(B)
Lucie Lecoutre
(L)
Stanislas Ledochowski
(S)
Rusel Leon
(R)
Claire Lepouse
(C)
Thomas Lescot
(T)
Mélanie Levrard
(M)
Marie Laure Lier
(ML)
Anne Lignereux
(A)
Benjamin Louart
(B)
Claire Maheu
(C)
Aurélie Maindron
(A)
Francois Mallard
(F)
Marie Reine Mallaret
(MR)
Bernard Mankikian
(B)
Christiane Manzon
(C)
Philippe Mardrus
(P)
Jacques Mariot
(J)
Audry Martin
(A)
Emmanuelle Martin
(E)
Maelle Martin
(M)
Pascale Martres
(P)
Virginie Maxime
(V)
Olivier Meunier
(O)
Ella-Pauline Meyer
(EP)
Ferhat Meziani
(F)
Sébastien Moschietto
(S)
Céline Muller
(C)
Elodie Munier-Marion
(E)
Caroline Neulier
(C)
François Nicolas
(F)
Jacques-Yves Nizou
(JY)
Christine Palitta
(C)
Michel Pascal
(M)
Olivier Passouant
(O)
René-Gilles Patrigeon
(RG)
Frédérique Pavillard
(F)
Sabine Peghaire
(S)
Christophe Perdrix
(C)
Jean-Sebastien Petit
(JS)
Judith Pibre
(J)
Walter Picard
(W)
Sylvie Picault
(S)
Santiago Picos Gil
(S)
Jérôme Pillot
(J)
Patrick Pina
(P)
Rémi Plattier
(R)
Laurent Poiron
(L)
Christian Pommier
(C)
Gaël Pradel
(G)
Cristian Prelipcean
(C)
Paul-Simon Pugliesi
(PS)
Vincent Quenee
(V)
Olga Raposo
(O)
Eve Remy
(E)
Sabine Reynaud Deforges
(S)
Jean-Christophe Richard
(JC)
Sylvie Ricome
(S)
Thomas Rimmele
(T)
Adrien Robine
(A)
Anne-Claude Roche
(AC)
Laetitia Rohr
(L)
Gwenaël Rolland-Jacob
(G)
Adrien Roques
(A)
Catherine Rougier
(C)
Jérôme Roustan
(J)
Mélanie Saint-Leger
(M)
Faouzi Saliba
(F)
Dominique Sechaud
(D)
Amine Si-Ali
(A)
Catherine Simac
(C)
Georges Simon
(G)
Michel Sirodot
(M)
Vincent Stoeckel
(V)
Philippe Tagawa
(P)
Marine Tasle
(M)
Fabrice Thiollière
(F)
Benoit Thiphagne
(B)
Aurélie Thomas-Hervieu
(A)
François Tinturier
(F)
Alexandre Tonnelier
(A)
Alexandre Toro
(A)
David Tranvan
(D)
Dominique Trivier
(D)
Gilles Troché
(G)
Rémi Trusson
(R)
Lionel Ursulet
(L)
Marie Laure Valdeyron
(ML)
Catherine Vallet
(C)
Vanessa Van Rossem
(V)
Laurence Vasse
(L)
Myriam Venelle
(M)
Christine Venot
(C)
Antoine Vieillard-Baron
(A)
Jean-François Vincent
(JF)
Michel Vitris
(M)
Hussein Yassine
(H)
Lassane Zanre
(L)
Cecile Zylberfajn
(C)
Informations de copyright
© 2024. The Author(s).
Références
Grasselli G, Zangrillo A, Zanella A, Antonelli M, Cabrini L, Castelli A, et al. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy. JAMA. 2020;323:1574–81.
pubmed: 32250385
pmcid: 7136855
doi: 10.1001/jama.2020.5394
Rouzé A, Martin-Loeches I, Povoa P, Makris D, Artigas A, Bouchereau M, et al. Relationship between SARS-CoV-2 infection and the incidence of ventilator-associated lower respiratory tract infections: a European multicenter cohort study. Intensive Care Med. 2021;47:188–98.
pubmed: 33388794
pmcid: 7778569
doi: 10.1007/s00134-020-06323-9
Lepape A, Machut A, Bretonnière C, Friggeri A, Vacheron C-H, Savey A, et al. Effect of SARS-CoV-2 infection and pandemic period on healthcare-associated infections acquired in intensive care units. Clin Microbiol Infect. 2023;29:530–6.
pubmed: 36441042
doi: 10.1016/j.cmi.2022.10.023
Massart N, Maxime V, Fillatre P, Razazi K, Ferré A, Moine P, et al. Characteristics and prognosis of bloodstream infection in patients with COVID-19 admitted in the ICU: an ancillary study of the COVID-ICU study. Annals of Intensive Care [Internet]. 2021 [cited 2023 Oct 26];11. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8708508/
Gangneux J-P, Dannaoui E, Fekkar A, Luyt C-E, Botterel F, De Prost N, et al. Fungal infections in mechanically ventilated patients with COVID-19 during the first wave: the French multicentre MYCOVID study. Lancet Respir Med. 2022;10:180–90.
pubmed: 34843666
doi: 10.1016/S2213-2600(21)00442-2
White PL, Dhillon R, Cordey A, Hughes H, Faggian F, Soni S, et al. A national strategy to diagnose COVID-19 associated invasive fungal disease in the ICU. Clin Infect Dis. 2020;
Vacheron C-H, Lepape A, Savey A, Machut A, Timsit JF, Comparot S, et al. Attributable mortality of ventilator-associated pneumonia among patients with COVID-19. Am J Respir Crit Care Med. 2022;206:161–9.
pubmed: 35537122
pmcid: 9887408
doi: 10.1164/rccm.202202-0357OC
Nseir S, Martin-Loeches I, Povoa P, Metzelard M, Du Cheyron D, Lambiotte F, et al. Relationship between ventilator-associated pneumonia and mortality in COVID-19 patients: a planned ancillary analysis of the coVAPid cohort. Crit Care. 2021;25:177.
pubmed: 34034777
pmcid: 8146175
doi: 10.1186/s13054-021-03588-4
Buetti N, Ruckly S, de Montmollin E, Reignier J, Terzi N, Cohen Y, et al. COVID-19 increased the risk of ICU-acquired bloodstream infections: a case-cohort study from the multicentric OUTCOMEREA network. Intensive Care Med. 2021;47:180–7.
pubmed: 33506379
pmcid: 7839935
doi: 10.1007/s00134-021-06346-w
Buetti N, Tabah A, Loiodice A, Ruckly S, Aslan AT, Montrucchio G, et al. Different epidemiology of bloodstream infections in COVID-19 compared to non-COVID-19 critically ill patients: a descriptive analysis of the Eurobact II study. Crit Care. 2022;26:319.
pubmed: 36258239
pmcid: 9578203
doi: 10.1186/s13054-022-04166-y
Alessandri F, Ceccarelli G, Migliara G, Baccolini V, Russo A, Marzuillo C, et al. High incidence of candidemia in critically Ill COVID-19 patients supported by veno-venous extracorporeal membrane oxygenation: a retrospective study. J Fungi (Basel). 2023;9:119.
pubmed: 36675940
doi: 10.3390/jof9010119
Nucci M, Barreiros G, Guimarães LF, Deriquehem VAS, Castiñeiras AC, Nouér SA. Increased incidence of candidemia in a tertiary care hospital with the COVID-19 pandemic. Mycoses. 2021;64:152–6.
pubmed: 33275821
doi: 10.1111/myc.13225
Mastrangelo A, Germinario BN, Ferrante M, Frangi C, Li Voti R, Muccini C, et al. Candidemia in coronavirus disease 2019 (COVID-19) patients: incidence and characteristics in a prospective cohort compared with historical non-COVID-19 controls. Clin Infect Dis. 2021;73:e2838–9.
pubmed: 33124650
doi: 10.1093/cid/ciaa1594
Alenazy H, Alghamdi A, Pinto R, Daneman N. Candida colonization as a predictor of invasive candidiasis in non-neutropenic ICU patients with sepsis: a systematic review and meta-analysis. Int J Infect Dis. 2021;102:357–62.
pubmed: 33157294
doi: 10.1016/j.ijid.2020.10.092
Blot S, Vandewoude K. Management of invasive candidiasis in critically ill patients. Drugs. 2004;64:2159–75.
pubmed: 15456333
doi: 10.2165/00003495-200464190-00002
Zuo T, Zhang F, Lui GCY, Yeoh YK, Li AYL, Zhan H, et al. Alterations in gut microbiota of patients With COVID-19 during time of hospitalization. Gastroenterology. 2020;159:944-955.e8.
pubmed: 32442562
doi: 10.1053/j.gastro.2020.05.048
Maeda Y, Motooka D, Kawasaki T, Oki H, Noda Y, Adachi Y, et al. Longitudinal alterations of the gut mycobiota and microbiota on COVID-19 severity. BMC Infect Dis. 2022;22:572.
pubmed: 35751044
pmcid: 9233337
doi: 10.1186/s12879-022-07358-7
Elmunzer BJ, Spitzer RL, Foster LD, Merchant AA, Howard EF, Patel VA, et al. Digestive manifestations in patients hospitalized with coronavirus disease 2019. Clin Gastroenterol Hepatol. 2021;19:1355-1365.e4.
pubmed: 33010411
doi: 10.1016/j.cgh.2020.09.041
El Moheb M, Naar L, Christensen MA, Kapoen C, Maurer LR, Farhat M, et al. Gastrointestinal complications in critically Ill patients with and without COVID-19. JAMA. 2020;324:1899–901.
pubmed: 32970139
pmcid: 7516799
doi: 10.1001/jama.2020.19400
Najafzadeh MJ, Shaban T, Zarrinfar H, Sedaghat A, Hosseinikargar N, Berenji F, et al. COVID-19 associated candidemia: from a shift in fungal epidemiology to a rise in azole drug resistance. Med Mycol. 2024;62:myae031.
pubmed: 38521982
doi: 10.1093/mmy/myae031
Siopi M, Georgiou P-C, Paranos P, Beredaki M-I, Tarpatzi A, Kalogeropoulou E, et al. Increase in candidemia cases and emergence of fluconazole-resistant. Euro Surveill. 2024;2024(29):2300661.
Vincent J-L, Sakr Y, Singer M, Martin-Loeches I, Machado FR, Marshall JC, et al. Prevalence and outcomes of infection among patients in intensive care units in 2017. JAMA. 2020;323:1478–87.
pubmed: 32207816
pmcid: 7093816
doi: 10.1001/jama.2020.2717
Tabah A, Buetti N, Staiquly Q, Ruckly S, Akova M, Aslan AT, et al. Epidemiology and outcomes of hospital-acquired bloodstream infections in intensive care unit patients: the EUROBACT-2 international cohort study. Intensive Care Med. 2023;49:178–90.
pubmed: 36764959
pmcid: 9916499
doi: 10.1007/s00134-022-06944-2
Le Gall JR, Lemeshow S, Saulnier F. A new simplified acute physiology score (SAPS II) based on a European/North American multicenter study. JAMA. 1993;270:2957–63.
pubmed: 8254858
doi: 10.1001/jama.1993.03510240069035
Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med. 1985;13:818–29.
pubmed: 3928249
doi: 10.1097/00003246-198510000-00009
Plachouras D, Lepape A, Suetens C. ECDC definitions and methods for the surveillance of healthcare-associated infections in intensive care units. Intensive Care Med. 2018;44:2216–8.
pubmed: 29797028
pmcid: 6280825
doi: 10.1007/s00134-018-5113-0
von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP, et al. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol. 2008;61:344–9.
doi: 10.1016/j.jclinepi.2007.11.008
COVID-ICU Group on behalf of the REVA Network and the COVID-ICU Investigators. Clinical characteristics and day-90 outcomes of 4244 critically ill adults with COVID-19: a prospective cohort study. Intensive Care Med. 2021;47:60–73.
Tay MZ, Poh CM, Rénia L, MacAry PA, Ng LFP. The trinity of COVID-19: immunity, inflammation and intervention. Nat Rev Immunol. 2020;20:363–74.
pubmed: 32346093
pmcid: 7187672
doi: 10.1038/s41577-020-0311-8
Beigel JH, Tomashek KM, Dodd LE, Mehta AK, Zingman BS, Kalil AC, et al. Remdesivir for the treatment of Covid-19—final report. N Engl J Med. 2020;383:1813–26.
pubmed: 32445440
doi: 10.1056/NEJMoa2007764
RECOVERY Collaborative Group, Horby P, Lim WS, Emberson JR, Mafham M, Bell JL, et al. Dexamethasone in Hospitalized Patients with Covid-19. N Engl J Med. 2021;384:693–704.
REMAP-CAP Investigators, Gordon AC, Mouncey PR, Al-Beidh F, Rowan KM, Nichol AD, et al. Interleukin-6 receptor antagonists in critically Ill patients with Covid-19. N Engl J Med. 2021;384:1491–502
Lamouche-Wilquin P, Souchard J, Pere M, Raymond M, Asfar P, Darreau C, et al. Early steroids and ventilator-associated pneumonia in COVID-19-related ARDS. Crit Care. 2022;26:233.
pubmed: 35918776
pmcid: 9344449
doi: 10.1186/s13054-022-04097-8
Khan S, Bilal H, Khan MN, Fang W, Chang W, Yin B, et al. Interleukin inhibitors and the associated risk of candidiasis. Front Immunol. 2024;15:1372693.
pubmed: 38605952
pmcid: 11007146
doi: 10.3389/fimmu.2024.1372693
Kayaaslan B, Eser F, Asilturk D, Oktay Z, Hasanoglu I, Kalem AK, et al. Development and validation of COVID-19 associated candidemia score (CAC-Score) in ICU patients. Mycoses. 2023;66:128–37.
pubmed: 36135336
doi: 10.1111/myc.13531
Ford D, Reveles K, Hoban C, Koutoubi S, Cadena J. Effects of COVID-19 hospitalization rates on the incidence of hospital-acquired Candida central line-associated bloodstream infection. Am J Infect Control. 2024;52:387–91.
pubmed: 37813280
doi: 10.1016/j.ajic.2023.10.002
Arastehfar A, Ünal N, Hoşbul T, Alper Özarslan M, Sultan Karakoyun A, Polat F, et al. Candidemia among coronavirus disease 2019 patients in Turkey admitted to intensive care units: a retrospective multicenter study. Open Forum Infect Dis. 2022;9:ofac078.
pubmed: 35345665
pmcid: 8903397
doi: 10.1093/ofid/ofac078
Schauwvlieghe AFAD, Rijnders BJA, Philips N, Verwijs R, Vanderbeke L, Van Tienen C, et al. Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study. Lancet Respir Med. 2018;6:782–92.
pubmed: 30076119
doi: 10.1016/S2213-2600(18)30274-1
Buil JB, Schouten JA, Wauters J, van de Hoeven H, Verweij PE, CAC-SDD study group. Absence of candidemia in critically ill patients with COVID-19 receiving selective digestive decontamination. Intensive Care Med. 2022;48:611–2.
pubmed: 35316350
pmcid: 8938637
doi: 10.1007/s00134-022-06651-y
de Jonge E, Schultz MJ, Spanjaard L, Bossuyt PMM, Vroom MB, Dankert J, et al. Effects of selective decontamination of digestive tract on mortality and acquisition of resistant bacteria in intensive care: a randomised controlled trial. Lancet. 2003;362:1011–6.
pubmed: 14522530
doi: 10.1016/S0140-6736(03)14409-1
Hurley JC. ICU-acquired candidemia within selective digestive decontamination studies: a meta-analysis. Intensive Care Med. 2015;41:1877–85.
pubmed: 26239730
doi: 10.1007/s00134-015-4004-x
Poissy J, Damonti L, Bignon A, Khanna N, Von Kietzell M, Boggian K, et al. Risk factors for candidemia: a prospective matched case-control study. Crit Care. 2020;24:109.
pubmed: 32188500
pmcid: 7081522
doi: 10.1186/s13054-020-2766-1
Thomas-Rüddel DO, Schlattmann P, Pletz M, Kurzai O, Bloos F. Risk factors for invasive candida infection in critically Ill patients: a systematic review and meta-analysis. Chest. 2022;161:345–55.
pubmed: 34673022
doi: 10.1016/j.chest.2021.08.081
Kazancioglu S, Bodur H, Mumcuoglu I, Bastug A, Ozbay BO, Aydos O, et al. Candidemia in critically ill COVID-19 patients: risk factors and impact on mortality. Heliyon. 2024;10: e28033.
pubmed: 38545189
pmcid: 10966599
doi: 10.1016/j.heliyon.2024.e28033
Dixit D, Jen P, Maxwell TD, Smoke S, McCracken JA, Cardinale-King M, et al. Risk factors and clinical outcomes of Candidemia Associated with severe COVID-19. Crit Care Explor. 2022;4: e0762.
pubmed: 36119397
pmcid: 9473786
doi: 10.1097/CCE.0000000000000762
Beştepe Dursun Z, Sipahioğlu H, Civan Yüksel R, Sav H, Çelik İ. Risk factors and lethality associated with Candidemia in severe COVID-19 patients. Curr Med Mycol. 2022;8:32–8.
pubmed: 36340438
pmcid: 9548077
Papadimitriou-Olivgeris M, Kolonitsiou F, Kefala S, Spiliopoulou A, Aretha D, Bartzavali C, et al. Increased incidence of candidemia in critically ill patients during the coronavirus disease 2019 (COVID-19) pandemic. Braz J Infect Dis. 2022;26: 102353.
pubmed: 35500645
pmcid: 9035354
doi: 10.1016/j.bjid.2022.102353
Dautzenberg MJD, Wekesa AN, Gniadkowski M, Antoniadou A, Giamarellou H, Petrikkos GL, et al. The association between colonization with carbapenemase-producing enterobacteriaceae and overall ICU mortality: an observational cohort study. Crit Care Med. 2015;43:1170–7.
pubmed: 25882764
pmcid: 4431676
doi: 10.1097/CCM.0000000000001028
Wolkewitz M, Vonberg RP, Grundmann H, Beyersmann J, Gastmeier P, Bärwolff S, et al. Risk factors for the development of nosocomial pneumonia and mortality on intensive care units: application of competing risks models. Crit Care. 2008;12:R44.
pubmed: 18384672
pmcid: 2447589
doi: 10.1186/cc6852
Venet F, Monneret G. Advances in the understanding and treatment of sepsis-induced immunosuppression. Nat Rev Nephrol. 2018;14:121–37.
pubmed: 29225343
doi: 10.1038/nrneph.2017.165
Davis CG, Chang K, Osborne D, Walton AH, Dunne WM, Muenzer JT. Increased susceptibility to candida infection following cecal ligation and puncture. Biochem Biophys Res Commun. 2011;414:37–43.
pubmed: 21939638
pmcid: 3195872
doi: 10.1016/j.bbrc.2011.09.017